QUIDELORTHO CORP (QDEL) Fundamental Analysis & Valuation

NASDAQ:QDEL • US2197981051

21.41 USD
+0.22 (+1.04%)
At close: Mar 5, 2026
21.4 USD
-0.01 (-0.05%)
After Hours: 3/5/2026, 8:16:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This QDEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

QDEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. QDEL has a bad profitability rating. Also its financial health evaluation is rather negative. A decent growth rate in combination with a cheap valuation! Better keep an eye on QDEL.


Dividend Valuation Growth Profitability Health

3

1. QDEL Profitability Analysis

1.1 Basic Checks

  • In the past year QDEL was profitable.
  • In the past year QDEL had a positive cash flow from operations.
  • In multiple years QDEL reported negative net income over the last 5 years.
  • In the past 5 years QDEL always reported a positive cash flow from operatings.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B

1.2 Ratios

  • QDEL has a Return On Assets (-19.62%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of -58.93%, QDEL is in line with its industry, outperforming 46.74% of the companies in the same industry.
  • The Return On Invested Capital of QDEL (0.90%) is better than 66.85% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for QDEL is significantly below the industry average of 8.91%.
Industry RankSector Rank
ROA -19.62%
ROE -58.93%
ROIC 0.9%
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

1.3 Margins

  • The Operating Margin of QDEL (2.01%) is better than 67.39% of its industry peers.
  • QDEL's Operating Margin has declined in the last couple of years.
  • QDEL has a Gross Margin (46.67%) which is comparable to the rest of the industry.
  • QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.01%
PM (TTM) N/A
GM 46.67%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. QDEL Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
  • The number of shares outstanding for QDEL has been increased compared to 1 year ago.
  • QDEL has more shares outstanding than it did 5 years ago.
  • QDEL has a worse debt/assets ratio than last year.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.59, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.59, QDEL perfoms like the industry average, outperforming 48.91% of the companies in the same industry.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that QDEL has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.29, QDEL is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACC0.1
WACC9.06%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • QDEL has a Current Ratio of 1.50. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
  • QDEL's Current ratio of 1.50 is on the low side compared to the rest of the industry. QDEL is outperformed by 75.54% of its industry peers.
  • A Quick Ratio of 0.90 indicates that QDEL may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.90, QDEL is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 0.9
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. QDEL Growth Analysis

3.1 Past

  • QDEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.59%, which is quite good.
  • The earnings per share for QDEL have been decreasing by -36.12% on average. This is quite bad
  • The Revenue has decreased by -1.89% in the past year.
  • QDEL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.44% yearly.
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.97% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.63% on average over the next years.
EPS Next Y20.65%
EPS Next 2Y25.68%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue Next Year2.46%
Revenue Next 2Y3.26%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

7

4. QDEL Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.10, the valuation of QDEL can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 94.57% of the companies listed in the same industry.
  • QDEL is valuated cheaply when we compare the Price/Earnings ratio to 26.74, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 8.37, the valuation of QDEL can be described as very reasonable.
  • 97.28% of the companies in the same industry are more expensive than QDEL, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (24.82), we can say QDEL is valued rather cheaply.
Industry RankSector Rank
PE 10.1
Fwd PE 8.37
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 96.20% of the companies in the same industry are more expensive than QDEL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.89
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as QDEL's earnings are expected to grow with 23.97% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y25.68%
EPS Next 3Y23.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. QDEL Dividend Analysis

5.1 Amount

  • No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QDEL Fundamentals: All Metrics, Ratios and Statistics

QUIDELORTHO CORP

NASDAQ:QDEL (3/5/2026, 8:16:35 PM)

After market: 21.4 -0.01 (-0.05%)

21.41

+0.22 (+1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners123.47%
Inst Owner Change-6.82%
Ins Owners0.61%
Ins Owner Change1.68%
Market Cap1.45B
Revenue(TTM)2.73B
Net Income(TTM)-1.13B
Analysts74.29
Price Target35.87 (67.54%)
Short Float %15.25%
Short Ratio9.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.64%
Min EPS beat(2)6.57%
Max EPS beat(2)70.71%
EPS beat(4)4
Avg EPS beat(4)198.19%
Min EPS beat(4)6.57%
Max EPS beat(4)691.7%
EPS beat(8)8
Avg EPS beat(8)130.06%
EPS beat(12)10
Avg EPS beat(12)87.81%
EPS beat(16)13
Avg EPS beat(16)76.08%
Revenue beat(2)2
Avg Revenue beat(2)1.67%
Min Revenue beat(2)0.14%
Max Revenue beat(2)3.19%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)5
Avg Revenue beat(8)1.61%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)11
Avg Revenue beat(16)2.09%
PT rev (1m)-4.59%
PT rev (3m)-4.59%
EPS NQ rev (1m)-46.01%
EPS NQ rev (3m)-46.01%
EPS NY rev (1m)-5.29%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)-4.22%
Revenue NQ rev (3m)-4.22%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 10.1
Fwd PE 8.37
P/S 0.53
P/FCF N/A
P/OCF 13.82
P/B 0.76
P/tB N/A
EV/EBITDA 7.89
EPS(TTM)2.12
EY9.9%
EPS(NY)2.56
Fwd EY11.95%
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)1.55
OCFY7.23%
SpS40.19
BVpS28.27
TBVpS-9.47
PEG (NY)0.49
PEG (5Y)N/A
Graham Number36.72
Profitability
Industry RankSector Rank
ROA -19.62%
ROE -58.93%
ROCE 1.14%
ROIC 0.9%
ROICexc 0.93%
ROICexgc 2.09%
OM 2.01%
PM (TTM) N/A
GM 46.67%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
ROICexc(3y)1.42%
ROICexc(5y)14.23%
ROICexgc(3y)4.43%
ROICexgc(5y)27.96%
ROCE(3y)1.75%
ROCE(5y)12.24%
ROICexgc growth 3Y-62.81%
ROICexgc growth 5Y-57.09%
ROICexc growth 3Y-55.09%
ROICexc growth 5Y-58.98%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 4.98
Cap/Depr 42.58%
Cap/Sales 6.89%
Interest Coverage 0.32
Cash Conversion 21.18%
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 0.9
Altman-Z 0.59
F-Score6
WACC9.06%
ROIC/WACC0.1
Cap/Depr(3y)43.8%
Cap/Depr(5y)143.82%
Cap/Sales(3y)6.96%
Cap/Sales(5y)8.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
EPS Next Y20.65%
EPS Next 2Y25.68%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%
Revenue Next Year2.46%
Revenue Next 2Y3.26%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y17.85%
EBIT growth 3Y-61.76%
EBIT growth 5Y-44.75%
EBIT Next Year67.83%
EBIT Next 3Y25.28%
EBIT Next 5YN/A
FCF growth 1Y25.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.75%
OCF growth 3Y-50.84%
OCF growth 5Y-30.09%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 7 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Undervalued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 10.1 and the Price/Book (PB) ratio is 0.76.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 20.65% in the next year.